K.J. Muldoon

K.J. Muldoon

patientb. 20240.0Global Dominance: 0.00%

K.J. Muldoon made headlines as the first baby to receive a personalized CRISPR gene therapy at just six months old, successfully treating a rare condition that caused toxic ammonia buildup in his blood.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions